A small dose of aspirin can reduce the mortality of patients with COVID-19 and the need for their hospitalization in intensive care and the use of ventilators to help patients with coronavirus; scientists at George Washington University in the US capital believe.
“When we learned about the link between blood clots and COVID-19, we realized that aspirin, used to prevent stroke and heart attacks, may be important for patients with COVID-19. Our study found an association between low-dose aspirin and a decrease in the severity of COVID-19,
as well as deaths,” the university’s website quotes the words of scientist Jonathan Chow.
The study was conducted from March to July 2020 on 400 patients in hospitals across the United States. Taking into account various demographic factors and concomitant diseases, the use of aspirin was associated with a reduced risk of using artificial ventilation (decreased by 44%), hospitalization in intensive care (decreased by 43%), and hospital mortality (decreased by 47%).
Chow said he hopes the study will encourage others to study the effect of aspirin on reducing lung damage in patients with COVID-19.
“Aspirin is inexpensive, easily available, and millions of people are already using it to treat their illnesses. The discovery of this link is a huge victory for those who want to reduce the risk of some of the most devastating effects of COVID-19,” the scientist added.
